Physician profile
Usman Asad
NPI 1891323903
$1,505.16
in general payments reported to CMS, 2019-2025
18 companies · $1,452 in 2025
The $1,452 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $53.06 · 2025: $1,452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,405 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,405.17 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $299.96 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $267.07 | 2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $176.20 | 2025 | |
| Janssen Biotech, INC. | $127.32 | 2025 | Tremfya |
| Incyte Corporation | $98.17 | 2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $75.80 | 2024-2025 | |
| Genzyme Corporation | $66.88 | 2025 | |
| Arcutis Biotherapeutics, INC. | $64.14 | 2025 | Zoryve |
| Ucb, INC. | $59.40 | 2025 | Bimzelx |
| Organon LLC | $47.25 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $45.04 | 2025 | Cabtreo, Jublia, Siliq |
| Amgen INC. | $44.41 | 2025 | Otezla |
| Pfizer INC. | $32.59 | 2025 | |
| Leo Pharma INC. | $29.04 | 2025 | Anzupgo |
| Strata Skin Sciences, INC. | $19.27 | 2025 | Xtrac |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $19.01 | 2025 | Taltz, Ebglyss |
| Mayne Pharma Commercial LLC | $18.31 | 2025 | |
| Galderma Laboratories, L.P. | $15.30 | 2025 | Nemluvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usman Asad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.